The compound has not progressed through a drug-approval pathway in any major jurisdiction, although Russian-federation peptide-bioregulator research has produced extensive preclinical and clinical-stage work
Cardioprotective Effects: Research indicates that this treatment can significantly reduce the size of a myocardial infarction, enhance healing following an injury, and promote blood vessel formation and vascular growth to improve blood flow
Increase metabolic rate and fat burning
Recalls & Warnings November 29, 2012 Sensa Settles Second False Advertising Lawsuit On November 27, 2012, Sensa Products LLC, maker of the Sensa Weight Loss System, announced it agreed to settle a false advertising lawsuit filed by the Nutritional Supplemental Task Force in California, without an admission of guilt
Safety Profile DSIP has a long history of human research and appears well tolerated